Research Article
Platelet-to-Monocyte Ratio as a Novel Promising Agent for the Prognosis of Hepatitis B Virus-Associated Decompensated Cirrhosis
Table 4
Clinical data according to the value of platelet-to-monocyte ratio.
| | Variables | Low group (PMR ≤ 118.62, n = 87) | High group (PMR > 118.62, n = 242) | |
| | Gender (female/male) | 12/75 | 72/170 | 0.003 | | Age (years) | 49 (42–59) | 51 (45–60) | 0.226 | | WBC (×109/L) | 7.09 (4.38–11.01) | 3.65 (2.58–5.50) | <0.001 | | Lymphocyte (×109/L) | 1.15 (0.61–1.69) | 0.84 (0.53–1.37) | 0.005 | | Monocyte (×109/L) | 0.71 (0.39–1.17) | 0.28 (0.20–0.45) | <0.001 | | Neutrophil (×109/L) | 5.24 (3.12–7.75) | 2.22 (1.59–3.59) | <0.001 | | Hemoglobin (g/L) | 100.05 ± 28.81 | 102.10 ± 24.49 | 0.525 | | PLT (×109/L) | 50.0 (31.0–73.0) | 66.5 (45.0–119.0) | <0.001 | | Albumin (g/L) | 28.75 ± 5.86 | 31.46 ± 6.11 | <0.001 | | ALT (U/L) | 42.9 (20.2–75.5) | 28.15 (18.55–58.53) | 0.073 | | AST (U/L) | 54.4 (33.8–97.4) | 41.7 (28.80–76.08) | 0.051 | | Total bilirubin (μmol/L) | 46.10 (23.50–139.40) | 25.00 (15.88–48.40) | <0.001 | | Serum creatinine (μmol/L) | 69.30 (57.10–95.20) | 63.05 (51.75–73.90) | 0.001 | | MELD score | 13.37 (9.02–21.74) | 8.69 (5.69–12.00) | <0.001 | | INR | 1.50 (1.27–1.87) | 1.37 (1.24–1.53) | <0.001 | | 30-day mortality (yes/no) | 17/70 (24.3%) | 4/238 (1.7%) | <0.001 |
|
|
Data are expressed as number, mean ± standard deviation, or median (interquartile range).
|
